New medications that spur weight loss and take care of diabetes have been having the general public—as well as pharmaceutical marketplace—by storm. The most up-to-date entrant, Zepbound, a short while ago joined Ozempic, Wegovy, Victoza and others inside a increasing course of medication identified as GLP-1 receptor agonists.adjustments in eyes